Euromedis Groupe SA (ALEMG) - Net Assets

Latest as of December 2025: €16.45 Million EUR ≈ $19.23 Million USD

Based on the latest financial reports, Euromedis Groupe SA (ALEMG) has net assets worth €16.45 Million EUR (≈ $19.23 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€39.49 Million ≈ $46.17 Million USD) and total liabilities (€23.04 Million ≈ $26.94 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Euromedis Groupe SA tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€16.45 Million
% of Total Assets	41.65%
Annual Growth Rate	-0.39%
5-Year Change	-60.11%
10-Year Change	-42.9%
Growth Volatility	33.44

Euromedis Groupe SA - Net Assets Trend (2009–2025)

This chart illustrates how Euromedis Groupe SA's net assets have evolved over time, based on quarterly financial data. See Euromedis Groupe SA defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Euromedis Groupe SA (2009–2025)

The table below shows the annual net assets of Euromedis Groupe SA from 2009 to 2025. For live valuation and market cap data, see market value of Euromedis Groupe SA.

Year	Net Assets	Change
2025-12-31	€16.45 Million ≈ $19.23 Million	-0.21%
2024-12-31	€16.48 Million ≈ $19.27 Million	-27.04%
2023-12-31	€22.59 Million ≈ $26.41 Million	-35.23%
2022-12-31	€34.88 Million ≈ $40.78 Million	-15.42%
2021-12-31	€41.24 Million ≈ $48.21 Million	+5.94%
2020-12-31	€38.93 Million ≈ $45.51 Million	+120.49%
2019-12-31	€17.66 Million ≈ $20.64 Million	-16.97%
2018-12-31	€21.26 Million ≈ $24.86 Million	-23.50%
2017-12-31	€27.80 Million ≈ $32.50 Million	-3.51%
2016-12-31	€28.81 Million ≈ $33.68 Million	+0.72%
2015-12-31	€28.60 Million ≈ $33.44 Million	+11.81%
2014-12-31	€25.58 Million ≈ $29.91 Million	+9.24%
2013-12-31	€23.42 Million ≈ $27.38 Million	+10.19%
2012-12-31	€21.25 Million ≈ $24.85 Million	+5.34%
2011-12-31	€20.18 Million ≈ $23.59 Million	+9.92%
2010-12-31	€18.35 Million ≈ $21.46 Million	+4.73%
2009-12-31	€17.52 Million ≈ $20.49 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Euromedis Groupe SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 144.6% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	€5.77 Million	35.10%
Other Comprehensive Income	€3.25 Million	19.73%
Other Components	€9.76 Million	59.36%
Total Equity	€16.45 Million	100.00%

Euromedis Groupe SA Competitors by Market Cap

The table below lists competitors of Euromedis Groupe SA ranked by their market capitalization.

Company	Market Cap
MSCM Holdings Bhd KLSE:0041	$14.11 Million
Klimator AB ST:KLIMAT	$14.11 Million
EcoBio Holdings Co. Ltd KQ:038870	$14.11 Million
BALAXI PHARMACEUTICALS LIMITED NSE:BALAXI	$14.12 Million
Mlk Foods Public Company Ltd WAR:MLK	$14.10 Million
TCS Group Holdings Bhd KLSE:0221	$14.10 Million
Investsmart Group Ltd AU:INV	$14.08 Million
In8bio Inc NASDAQ:INAB	$14.08 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Euromedis Groupe SA's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 16,483,808 to 16,449,919, a change of -33,889 (-0.2%).
Net loss of 100,000 reduced equity.
Other comprehensive income increased equity by 41,043.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	€-100.00K	-0.61%
Other Comprehensive Income	€41.04K	+0.25%
Other Changes	€25.07K	+0.15%
Total Change	€-	-0.21%

Book Value vs Market Value Analysis

This analysis compares Euromedis Groupe SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.89x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has increased from 0.77x to 0.89x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2009-12-31	€6.63	€5.10	x
2010-12-31	€7.28	€5.10	x
2011-12-31	€6.76	€5.10	x
2012-12-31	€7.12	€5.10	x
2013-12-31	€7.84	€5.10	x
2014-12-31	€8.56	€5.10	x
2015-12-31	€9.58	€5.10	x
2016-12-31	€9.64	€5.10	x
2017-12-31	€9.30	€5.10	x
2018-12-31	€7.17	€5.10	x
2019-12-31	€5.90	€5.10	x
2020-12-31	€10.90	€5.10	x
2021-12-31	€11.51	€5.10	x
2022-12-31	€11.87	€5.10	x
2023-12-31	€7.93	€5.10	x
2024-12-31	€5.79	€5.10	x
2025-12-31	€5.72	€5.10	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Euromedis Groupe SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -0.61%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -0.25%
• Asset Turnover: 1.03x
• Equity Multiplier: 2.40x
Recent ROE (-0.61%) is below the historical average (2.62%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2009	-14.38%	-3.93%	1.20x	3.06x	€-4.28 Million
2010	4.40%	1.26%	1.16x	3.02x	€-1.03 Million
2011	-4.07%	-1.25%	1.17x	2.78x	€-2.85 Million
2012	5.07%	1.45%	1.35x	2.59x	€-1.05 Million
2013	9.36%	2.90%	1.38x	2.34x	€-149.00K
2014	9.97%	3.49%	1.32x	2.17x	€-7.60K
2015	8.63%	3.47%	1.26x	1.97x	€-391.10K
2016	3.49%	1.38%	1.29x	1.97x	€-1.88 Million
2017	-0.52%	-0.20%	1.29x	2.06x	€-2.93 Million
2018	-23.14%	-6.47%	1.51x	2.37x	€-7.05 Million
2019	-21.52%	-4.92%	1.28x	3.41x	€-5.56 Million
2020	58.55%	11.72%	2.09x	2.39x	€18.79 Million
2021	5.50%	2.02%	1.54x	1.77x	€-1.84 Million
2022	-17.16%	-10.99%	0.91x	1.73x	€-9.43 Million
2023	58.03%	35.03%	0.81x	2.05x	€10.85 Million
2024	-37.06%	-16.87%	0.93x	2.35x	€-7.76 Million
2025	-0.61%	-0.25%	1.03x	2.40x	€-1.74 Million

Industry Comparison

This section compares Euromedis Groupe SA's net assets metrics with peer companies in the Medical Distribution industry.

Industry Context

Industry: Medical Distribution
Average net assets among peers: $23,754,027
Average return on equity (ROE) among peers: 8.26%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Euromedis Groupe SA (ALEMG)	€16.45 Million	-14.38%	1.40x	$14.11 Million
Bastide Le Confort Médical SA (BLC)	$35.71 Million	16.49%	1.06x	$196.28 Million
Metrics in Balance NV (MLMIB)	$11.80 Million	0.02%	0.05x	$144.89K

About Euromedis Groupe SA

PA:ALEMG France Medical Distribution

Market Cap

$17.03 Million

€14.57 Million EUR

Market Cap Rank

#26165 Global

#437 in France

Share Price

€5.10

Change (1 day)

+4.08%

52-Week Range

€3.83 - €5.75

All Time High

€24.90